TrialJournal of hematology & oncology2016

Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients.

Pin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.